Search Results - "Llorca Cristina"

Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study by Fernández, Ana, Salgado, Mercedes, García, Adelaida, Buxò, Elvira, Vera, Ruth, Adeva, Jorge, Jiménez-Fonseca, Paula, Quintero, Guillermo, Llorca, Cristina, Cañabate, Mamen, López, Luis Jesús, Muñoz, Andrés, Ramírez, Patricia, González, Paula, López, Carlos, Reboredo, Margarita, Gallardo, Elena, Sanchez-Cánovas, Manuel, Gallego, Javier, Guillén, Carmen, Ruiz-Miravet, Nuria, Navarro-Pérez, Víctor, De la Cámara, Juan, Alés-Díaz, Inmaculada, Pazo-Cid, Roberto Antonio, Carmona-Bayonas, Alberto

“…Treatment with nab-paclitaxel plus gemcitabine increases survival in patients with metastatic pancreatic cancer. However, the assessment of treatment efficacy…”
Get full text

Transcriptomic characterization of endometrial cancer in order to find new therapeutic targets by Parra-Grande, Monica, Ore-Arce, Martin, Llorca, Cristina, Poveda, Andres

“…Abstract only e17113 Background: There are unmet needs for targeted therapy in Endometrial Cancer (EC). The integrated genomic characterization of EC provided…”
Get full text

A scoring system to predict recurrence in breast cancer patients by Paredes-Aracil, Esther, Palazón-Bru, Antonio, Folgado-de la Rosa, David Manuel, Ots-Gutiérrez, José Ramón, Llorca-Ferrándiz, Cristina, Alonso-Hernández, Sonia, Coloma-Lidón, José Vicente, Gil-Guillén, Vicente Francisco

“…Current breast cancer recurrence prediction models have limitations for clinical practice (statistical methodology, simplicity and specific populations). We…”
Get full text

Positron emission tomography: false positive result due to splenic uptake in an extension study in bronchial carcinoma. A case report by Orts Giménez, David, Jiménez Yáñez, Rosa, Esquerdo Galiana, Gaspar, Galán Dávila, Antonia, Llorca Martínez, Eleuterio, Díaz Castellano, Manuel, Llorca Ferrándiz, Cristina

“…Lung cancer is one of the most common malignant diseases. Many tests and techniques are used in the staging of this disease, including positron emission…”
Get full text

First-line treatment with irinotecan and raltitrexed in metastatic colorectal cancer. Mature results of a multicenter phase II study by Aparicio, Jorge, Vicent, José M, Maestu, Inmaculada, Bosch, Carles, Galán, Antonio, Busquier, Isabel, Llorca, Cristina, Garcerá, Salvador, Campos, Juan M, López-Tendero, Pedro, Balcells, Miquel

“…The combination of irinotecan and raltitrexed is safe and active in 5-fluorouracil-refractory, metastatic colorectal cancer (CRC), with the advantage of its…”
Get more information

The value of 18F-FDG PET/CT in two cases of Primary Pericardial Mesothelioma by Utrera-Costero, Ana, Bernal-Vergara, Juan Camilo, Olivan-Sasot, Patricia, Yepes-Agudelo, Ana María, Ruiz-Llorca, Cristina, Vera-Pinto, Victor José, Bello-Arqués, Pilar

Get full text

Complete atrioventricular block induced by rituximab in monotherapy in an aged patient with non-Hodgkin’s diffuse large B-cell lymphoma by Cervera Grau, José Manuel, Galiana, Gaspar Esquerdo, Candela, Ana Belso, Ferrándiz, Cristina Llorca, Marroquí, Asunción Juárez, Escalante, Sonia Maciá

“…Rituximab is a treatment option to non-Hodgkin’s diffuse large B-cell lymphoma (NHDLBCL) in advanced stage and comorbility. It is known the cardiotoxicity…”
Get full text

Adjuvant Docetaxel for High-Risk, Node-Negative Breast Cancer by Martín, Miguel, Seguí, Miguel A, Antón, Antonio, Ruiz, Amparo, Ramos, Manuel, Adrover, Encarna, Aranda, Ignacio, Rodríguez-Lescure, Alvaro, Große, Regina, Calvo, Lourdes, Barnadas, Agustí, Isla, Dolores, Martinez del Prado, Purificación, Ruiz Borrego, Manuel, Zaluski, Jerzy, Arcusa, Angels, Muñoz, Montserrat, López Vega, José M, Mel, José R, Munarriz, Blanca, Llorca, Cristina, Jara, Carlos, Alba, Emilio, Florián, Jesús, Li, Junfang, López García-Asenjo, José A, Sáez, Amparo, Rios, María José, Almenar, Sergio, Peiró, Gloria, Lluch, Ana

“…As compared with the standard regimen, the combination of docetaxel, doxorubicin, and cyclophosphamide reduced the risk of recurrence of node-negative…”
Get full text

A Descriptive Study of 103 Primary Cutaneous B-Cell Lymphomas: Clinical and Pathological Characteristics and Treatment from the Spanish Lymphoma Oncology Group (GOTEL) by Martínez-Banaclocha, Natividad, Martínez-Madueño, Francisca, Caballé, Berta, Badia, Joan, Blanes, Mar, Bujanda, David Aguiar, Calvo, Virginia, Gómez Codina, Jose, Blanco, Cristina Quero, Espinosa, Pablo, Lavernia, Javier, Arroyo, Francisco Ramón García, Risueño, María Guirado, Llorca, Cristina, Cumeras, Raquel, Pulla, Mariano Provencio, Gumà, Josep

“…Primary cutaneous B-cell lymphomas (PCBCLs) are B-cell lymphomas that can occur in the skin without evidence of extracutaneous involvement. The 2005 WHO/EORTC…”
Get full text

First-line treatment with panitumumab plus FOLFIRI in elderly patients with RAS/BRAF wild-type unresectable metastatic colorectal cancer and good performance status: OPALO trial by Feliu, Jaime, Salud, Antonieta, Pineda Losada, Estela, Alonso, Vicente, Cubillo, Antonio, Soler, Gemma, Carmona, Alberto, Ruíz Casado, Ana, Martinez-Amores, Brenzo, Guillot Morales, Monica, Llorca, Cristina, Castañon Lopez, Carmen, Soler Gonzalez, Gemma, Escudero, Pilar, Macias Declara, Ismael, Aparicio, Jorge

“…Abstract only…”
Get full text

The value of 18 F-FDG PET/CT in two cases of Primary Pericardial Mesothelioma by Utrera-Costero, Ana, Bernal-Vergara, Juan Camilo, Olivan-Sasot, Patricia, Yepes-Agudelo, Ana María, Ruiz-Llorca, Cristina, Vera-Pinto, Victor José, Bello-Arqués, Pilar

Get full text

State-of-the-art of bone marrow imaging in multiple myeloma by Martí-Bonmatí, Luis, Ramirez-Fuentes, Cristina, Alberich-Bayarri, Ángel, Ruiz-Llorca, Cristina

“…PURPOSE OF REVIEWMultiple myeloma is a common hematological malignancy arising in the bone marrow. Bone lesions were initially depicted with conventional…”
Get full text

Molecular predictors of efficacy of adjuvant weekly paclitaxel in early breast cancer by Martín, Miguel, Rodríguez-Lescure, Álvaro, Ruiz, Amparo, Alba, Emilio, Calvo, Lourdes, Ruiz-Borrego, Manuel, Santaballa, Ana, Rodríguez, César A, Crespo, Carmen, Abad, Mar, Domínguez, Severina, Florián, Jesús, Llorca, Cristina, Méndez, Miguel, Godes, María, Cubedo, Ricardo, Murias, Adolfo, Batista, Norberto, García, María José, Caballero, Rosalía, de Álava, Enrique

“…Treatment with fluororacil, epirubicin, and cyclophosphamide followed by weekly paclitaxel (FEC-P) yielded superior disease-free survival than FEC in the…”
Get full text

Positron emission tomography: a false negative result in cystic encephalic mestastases from a small cell bronchial carcinoma by Orts Giménez, David, Jiménez Yáñez, Rosa, Galán Dávila, Antonia, Esquerdo Galiana, Gaspar, Llorca Martínez, Eleuterio, Belso Candela, Ana, Mallada, Javier, Llorca Ferrándiz, Cristina, Cervera, José Manuel

“…Lung cancer represents one of the most common malignant diseases. Many investigations are used in the staging study including, most recently, PET. We present a…”
Get full text

Extragonadal nongestational choriocarcinoma involving the lung: a report of three cases by Aparicio, J, Oltra, A, Martínez-Moragón, E, Llorca, C, Gómez-Aldaraví, L, Pastor, M

“…Primary choriocarcinoma of the lung is an extremely rare tumour, with about 20 cases reported in the literature. The case records of 3 female patients with…”
Get more information

Factors Associated with the Selection of First-line Bevacizumab plus Chemotherapy and Clinical Response in HER2-negative Metastatic Breast Cancer: ONCOSUR AVALOX Study by Manso, Luís, Palomo, Andrés García, Pérez Carrión, Ramón, Cassinello, Javier, Gallegos Sancho, Isabel, Chacón López-Muñiz, Ignacio, Olier, Clara, Fernández-Aramburo, Antonio, Llorca, Cristina, González, Xavier, Llorente, Rosa, Torregrosa, Dolores, Álvarez, Iñaki, Gálve, Elena, Bueno, Coralia, Garau, Isabel, García, María José, González-Santiago, Santiago, Ballesteros, Ana Isabel, Blanco, Esperanza, Galán, Antonio, González, Sonia, Perelló, Antonia, Cortés-Funes, Hernán, Grávalos, Cristina

“…To evaluate factors associated with the selection of first-line bevacizumab plus chemotherapy and clinical response in HER2-negative metastatic breast cancer…”
Get full text

Prognostic factors influencing the selection of bevacizumab combined with chemotherapy in patients with HER2-negative metastatic breast cancer in routine clinical practice: Oncosur-Avalox—Observational cross-sectional study by Manso, Luis, Garcia-Palomo, Andres, Perez-Carrion, Ramon, Chacon, Jose Ignacio, Mielgo Rubio, Xabier, Gallegos Sancho, Isabel, Cassinello, Javier, Llorente, Rosa, Calvo, Elena Galve, Llorca, Cristina, Alvarez, Inaki, Fernandez, Antonio, Catalan, Gustavo, Garcia Lopez, Maria Jose, Torregrosa, Maria Dolores, Blanco, Esperanza, Bueno, Coralia, Perello, Antonia, Méndez, Miguel, Cortes-Funes, Hernan

“…Abstract only e12020 Background: Combining bevacizumab (BEV) with chemotherapy (CT) improves survival in HER2-negative metastatic breast cancer (MBC). We…”
Get full text

Toxicidad en el intestino delgado inducida por 5-fluorouracilo en un paciente con carcinoma colorrectal by Ferrándiz, Cristina Llorca, Galiana, Gaspar Esquerdo, Cervera Grau, José Manuel, Briceño García, Hugo Claudio, Calduch Brosetta, Juan Vicente, del Pino Cuadrado, José

Get full text

Observational cross-sectional study to evaluate the prognostic factors influencing the selection of bevacizumab combined with chemotherapy in patients with HER2-negative metastatic breast cancer in routine clinical practice. ONCOSUR-AVALOX study by Manso, Luis, Perez-Carrion, Ramon, Chacon Lopez-Muniz, Jose Ignacio, Garcia Palomo, Andres, Galve Calvo, Elena, Llorente, Rosa M., Cassinello, Javier, Catalan, Gustavo, Llorca, Cristina, Torregrosa, Maria Dolores, Alvarez, Inaki, Gallegos Sancho, Isabel, Blanco, Esperanza, Oruezabal, Mauro, Mielgo Rubio, Xabier, Garcia Lopez, Maria Jose, Hernando, Blanca, Enrech, Santos, Lara, Miguel Angel, Cortes-Funes, Hernan

“…Abstract only e11074 Background: Combining bevacizumab (BEV) with chemotherapy (CT) improves survival in HER2-negative metastatic breast cancer (MBC). We…”
Get full text

Effectiveness of darbepoetin alfa in a cohort of oncology patients with chemotherapy-induced anaemia. Relationship between variation in three fatigue-specific quality of life questionnaire scores and change in haemoglobin level by Esquerdo, Gaspar, Llorca, Cristina, Cervera, José Manuel, Orts, David, Juárez, Asunción, Carrato, Alfredo

“…Background Cancer patients with chemotherapy-induced anaemia (CIA) often experience cancer-related fatigue (CRF). Darbepoetin alfa (DA) once every 3 weeks…”
Get full text